Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|August 14, 2020
Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic ActivitiesAlessia Bertamino, Carmine Ostacolo, Alicia Medina, et al.European Journal of Medicinal Chemistry|May 22, 2022
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer modelsVeronica Di Sarno, Pia Giovannelli, Alicia Medina-Peris, et al.Journal of Medicinal Chemistry|June 26, 2018
Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic ActivityAlessia Bertamino, Nunzio Iraci, Carmine Ostacolo, et al.Chemmedchem|May 6, 2025
Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary CharacterizationGerardina Smaldone, Maria Rosaria Miranda, Francesca Di Matteo, et al.Journal of Medicinal Chemistry|May 23, 2024
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 ChannelNunzio Iraci, Lidia Carotenuto, Tania Ciaglia, et al.Journal of Medicinal Chemistry|August 16, 2022
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant ActivitySimona Musella, Lidia Carotenuto, Nunzio Iraci, et al.European Journal of Medicinal Chemistry|September 27, 2021
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterizationVeronica Di Sarno, Gianluigi Lauro, Simona Musella, et al.Journal of Medicinal Chemistry|December 10, 2019
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel ActivatorsCarmine Ostacolo, Francesco Miceli, Veronica Di Sarno, et al.European Journal of Medicinal Chemistry|January 17, 2024
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterizationTania Ciaglia, Vincenzo Vestuto, Veronica Di Sarno, et al.Journal of Medicinal Chemistry|July 24, 2025
Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target DeconvolutionTania Ciaglia, Valeria Napolitano, Maria Rosaria Miranda, et al.Pageof 5